[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 7um3 Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab. |
Resolution | 2.3983 Å |
Binding residue (original residue number in PDB) | Y33 S97 W100C |
Binding residue (residue number reindexed from 1) | Y31 S98 W104 |
|